Omeros Corp
F:3O8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
Omeros Corp
F:3O8
|
US |
|
Corbion NV
AEX:CRBN
|
NL |
|
Phunware Inc
F:2RJA
|
US |
|
Clever Leaves Holdings Inc
OTC:CLVR
|
CO |
|
T
|
Tradeweb Markets Inc
F:4T0
|
US |
|
G
|
Geox SpA
F:GHH
|
IT |
|
O
|
Obayashi Corp
OTC:OBYCF
|
JP |
|
Link Bilgisayar Sistemleri Yazilimi ve Donanimi Sanayi ve Ticaret AS
IST:LINK.E
|
TR |
|
Laurentian Bank of Canada
TSX:LB
|
CA |
|
Sofina SA
XBRU:SOF
|
BE |
|
C
|
China High Speed Transmission Equipment Group Co Ltd
SWB:BGR
|
KY |
|
ImagineAR Inc
OTC:IPNFF
|
CA |
|
Apollo Global Management Inc
NYSE:APO
|
US |
Intrinsic Value
Is 3O8 undervalued or overvalued?
See the intrinsic value estimate for 
Omeros Corp and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
3O8 looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with 3O8’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Omeros Does
Omeros Corp is a biotechnology company that develops medicines for serious diseases, especially disorders tied to inflammation, the complement system, and the brain and nervous system. Its work is centered on creating drug candidates in-house, testing them in clinical studies, and moving the most promising ones toward regulatory approval. The company does not sell a broad range of consumer products; it is a drug developer.
- Headquarters
- United States of America US
- Employees
- 175
- IPO date
- Oct 8, 2009
Omeros has no economic moat
Omeros Corp lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.
Read the full moat analysis
Revenue & Expenses Breakdown
Omeros Corp
Earnings Waterfall
Omeros Corp
The intrinsic value for Omeros Corp (3O8) under the Base Case is hidden EUR.
Compared with the current market price of 14.25 EUR, the stock appears hidden.